Cardiogen 20 mg

Steroids Dragon Pharma Peptides

$70.00

Dragon Pharma Cardiogen 20 mg – Synthetic Tetrapeptide for Cardiovascular Research

✔ Synthetic AEDR tetrapeptide bioregulator ✔ Studied for cardioprotective mechanisms ✔ Regulates fibroblast activity & apoptosis ✔ USA domestic shipping available

Dragon Pharma Cardiogen 20 mg is a synthetic tetrapeptide bioregulator with the amino acid sequence Ala-Glu-Asp-Arg (AEDR). This compound has been investigated in experimental models for its potential cardiovascular support properties, including regulation of fibroblast activity, protection of cardiac myocytes from programmed cell death, and promotion of tissue repair mechanisms.

Each vial contains 20 mg of lyophilized Cardiogen in a 2 mL format, requiring reconstitution with bacteriostatic water before use. Cardiogen represents a targeted research tool for investigating the molecular pathways involved in cardiac tissue preservation and recovery. For related research compounds, explore our peptides category and specifically SS-31 50 mg for mitochondrial function studies.

What Makes Cardiogen Valuable in Research?

Cardiogen belongs to a class of short-chain peptides known for their tissue-specific bioregulatory properties. The AEDR sequence has been studied for its ability to influence cellular processes relevant to cardiovascular health, including the modulation of fibroblast activity, inhibition of apoptosis in cardiac muscle cells, and support of regenerative responses in cardiac tissue.

Researchers value Cardiogen for its targeted approach to studying cardiac physiology. Its defined sequence and mechanism of action make it a practical tool for investigating the molecular basis of myocardial protection and repair. For investigators exploring broader cardiovascular research applications, MOTS-C offers complementary avenues in metabolic and cardiac function studies.

Current scientific literature on Khavinson peptides, including Cardiogen, can be accessed through the PubMed database, where researchers can review peer-reviewed studies on their biological activity and experimental applications.

Key Research Applications for Dragon Pharma Cardiogen

✔ Investigation of cardiac fibroblast regulation
✔ Evaluation of anti-apoptotic mechanisms in cardiomyocytes
✔ Research on myocardial tissue repair and regeneration
✔ Studies of peptide bioregulation in cardiovascular models
✔ Preclinical models of cardiac protection and recovery

For Research Purposes Only

Cardiogen 20 mg is intended for research use only and is not approved for human consumption. Proper handling, reconstitution, and experimental protocols are essential for reliable results. For studies on vascular health, TB 500 provides additional research avenues in tissue repair and angiogenesis.

Dispatched within 24 hours in plain, discreet packaging.

Additional Information

Categories:

Steroids

Brand: Dragon Pharma

Manufacturer: Dragon Pharma

Dosage Info: <div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel"> <section class="tab-panel" id="panel-usage"> <h2>Dosage & Usage Guidelines</h2> <div class="info-card warning"> <p><strong>For research and laboratory use only.</strong> Dragon Pharma Cardiogen 20 mg is a synthetic tetrapeptide bioregulator. Proper reconstitution, handling, and experimental design are essential for obtaining reliable data.</p> </div> <h3>Reconstitution Protocol</h3> <ul class="usage-highlights"> <li>✔ Use sterile bacteriostatic water for injection</li> <li>✔ Add appropriate volume to achieve desired concentration</li> <li>✔ Swirl gently to dissolve – do not shake vigorously</li> <li>✔ Store reconstituted solution at 2–8°C</li> </ul> <p>Reconstitute the lyophilized powder using bacteriostatic water to a concentration suitable for your research protocol. The 20 mg format allows for flexible dosing across a range of experimental models. Always use aseptic technique during preparation to maintain peptide integrity.</p> <h3>Typical Research Parameters</h3> <p>In research settings, Cardiogen is typically administered via subcutaneous or intraperitoneal injection. Dosing schedules and concentrations vary widely depending on the experimental design, animal model, and specific research objectives.</p> <ul> <li>✔ Commonly used in cardiovascular protection studies</li> <li>✔ Often combined with histological and molecular analysis</li> <li>✔ Used to investigate apoptosis inhibition and fibroblast regulation</li> <li>✔ Research models include cardiac injury and recovery paradigms</li> </ul> <h3>Factors to Consider in Research Protocols</h3> <ul> <li>Short-chain peptide with specific bioregulatory properties</li> <li>Reconstitution stability is limited; prepare fresh solutions for each use</li> <li>Individual variation in response may be observed across subjects</li> <li>Storage conditions significantly impact peptide stability</li> </ul> <div class="info-card"> <p><strong>Research note:</strong> Cardiogen is part of the Khavinson peptide class, known for their tissue-specific bioregulatory effects. Its short AEDR sequence provides a defined molecular tool for investigating cardiac protection mechanisms, including the regulation of apoptosis and fibroblast activity in myocardial tissue.</p> </div> </section> </div>

Reviews:

(0 customer reviews)